|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-6-12
|
|
pubmed:abstractText |
To evaluate the expression of chromogranin A, a marker for neuroendocrine (NE) differentiation, in patients with lymph node-positive prostate cancer to determine its prognostic significance. NE cells are involved in cellular growth and differentiation in both normal and pathologic conditions of the prostate.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1247-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16697447-Adenocarcinoma,
pubmed-meshheading:16697447-Aged,
pubmed-meshheading:16697447-Aged, 80 and over,
pubmed-meshheading:16697447-Chromogranin A,
pubmed-meshheading:16697447-Chromogranins,
pubmed-meshheading:16697447-Follow-Up Studies,
pubmed-meshheading:16697447-Humans,
pubmed-meshheading:16697447-Lymphatic Metastasis,
pubmed-meshheading:16697447-Male,
pubmed-meshheading:16697447-Middle Aged,
pubmed-meshheading:16697447-Neurosecretory Systems,
pubmed-meshheading:16697447-Prognosis,
pubmed-meshheading:16697447-Prostatic Neoplasms,
pubmed-meshheading:16697447-Tumor Markers, Biological
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer.
|
|
pubmed:affiliation |
Department of Urology, Loyola University Stritch School of Medicine, Maywood, Illinois, USA.
|
|
pubmed:publicationType |
Journal Article
|
